Editorial: liver transplantation in patients with non-alcoholic fatty liver disease and obesity

S. A. Townsend; P. N. Newsome

doi:10.1111/apt.14179

Editorial: liver transplantation in patients with non-alcoholic fatty liver disease and obesity

S. A. Townsend, P. N. Newsome

Immunology and Immunotherapy

Research output: Contribution to journal › Editorial › peer-review

2 Citations (Scopus)

Original language	English
Pages (from-to)	459-460
Number of pages	2
Journal	Alimentary Pharmacology and Therapeutics
Volume	46
Issue number	4
DOIs	https://doi.org/10.1111/apt.14179
Publication status	Published - Aug 2017

Bibliographical note

Funding Information:
Declaration of personal interests: P. N. Newsome has served as a speaker, a consultant and an advisory board member for AbbVie, Boehringer Ingelheim, Gilead, Intercept, Janssen, Novartis, Novo Nordisk, Pharmaxis, and Shire, and has received research funding from these organisations on behalf of the University of Birmingham.

ASJC Scopus subject areas

Hepatology
Gastroenterology
Pharmacology (medical)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/apt.14179

Cite this

@article{04e651785cfb4012a3a7059060e0a30a,

title = "Editorial: liver transplantation in patients with non-alcoholic fatty liver disease and obesity",

author = "Townsend, {S. A.} and Newsome, {P. N.}",

note = "Funding Information: Declaration of personal interests: P. N. Newsome has served as a speaker, a consultant and an advisory board member for AbbVie, Boehringer Ingelheim, Gilead, Intercept, Janssen, Novartis, Novo Nordisk, Pharmaxis, and Shire, and has received research funding from these organisations on behalf of the University of Birmingham.",

year = "2017",

month = aug,

doi = "10.1111/apt.14179",

language = "English",

volume = "46",

pages = "459--460",

journal = "Alimentary Pharmacology and Therapeutics",

issn = "0269-2813",

publisher = "Wiley",

number = "4",

}

TY - JOUR

T1 - Editorial

T2 - liver transplantation in patients with non-alcoholic fatty liver disease and obesity

AU - Townsend, S. A.

AU - Newsome, P. N.

N1 - Funding Information: Declaration of personal interests: P. N. Newsome has served as a speaker, a consultant and an advisory board member for AbbVie, Boehringer Ingelheim, Gilead, Intercept, Janssen, Novartis, Novo Nordisk, Pharmaxis, and Shire, and has received research funding from these organisations on behalf of the University of Birmingham.

PY - 2017/8

Y1 - 2017/8

UR - http://www.scopus.com/inward/record.url?scp=85023644768&partnerID=8YFLogxK

U2 - 10.1111/apt.14179

DO - 10.1111/apt.14179

M3 - Editorial

C2 - 28707791

AN - SCOPUS:85023644768

SN - 0269-2813

VL - 46

SP - 459

EP - 460

JO - Alimentary Pharmacology and Therapeutics

JF - Alimentary Pharmacology and Therapeutics

IS - 4

ER -